logo
#

Latest news with #TTI

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025-Exclusive Report by Meticulous Research®
Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025-Exclusive Report by Meticulous Research®

Malaysian Reserve

time11 hours ago

  • Business
  • Malaysian Reserve

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025-Exclusive Report by Meticulous Research®

Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ — According to a new market research report titled 'Time Temperature Indicator Market by Technology (Chemical, Electronic, Hybrid), Application (Cold Chain, Food, Pharma), End User (F&B, Healthcare) & Geography – Global Forecast to 2035″, the time temperature Indicator market is projected to reach $1.57 billion by 2035, up from an estimated $821 million in 2024, growing at a CAGR of 6.2% during the forecast period. The growth of the time temperature indicator market is mainly driven by the critical importance of precise temperature monitoring throughout the cold chain for temperature-sensitive products valued at over $250 billion annually. Stringent regulations in pharmaceutical industry and expanding e-commerce supply chains are fueling adoption of smart TTI labels with digital integration capabilities. Recent FDA guidelines requiring enhanced temperature monitoring for vaccine distribution and biologics storage have created new compliance-driven demand for Critical Time Temperature Indicators (CTTI) and Critical Temperature Indicators (CTI). The industry is experiencing significant technological transformation through IoT integration, wireless connectivity, and multi-parameter monitoring solutions. Leading TTI manufacturers are investing heavily in eco-friendly biodegradable labels and AI-powered analytics platforms to improve supply chain visibility, reduce product spoilage, and enhance regulatory compliance. For more comprehensive insights, download the FREE report sample: Key Market Drivers and Trends The Time Temperature Indicator market is experiencing remarkable transformation through increasingly sophisticated partnerships between TTI manufacturers and IoT platform companies. These collaborations are driving rapid innovation in smart packaging solutions, creating robust monitoring ecosystems that address critical challenges in cold chain management. Emerging trends demonstrate a multifaceted approach to market development. Manufacturers are intensely focusing on developing Bluetooth-enabled TTI devices that provide real-time alerts and data analytics, integrating advanced color-change chemistry, and creating comprehensive regulatory compliance solutions. The industry is witnessing a significant shift towards sustainable packaging technologies, with particular emphasis on creating biodegradable TTI solutions that seamlessly integrate into existing supply chain systems. Growth Opportunities The market presents significant growth opportunities that extend far beyond traditional temperature monitoring. Integration with IoT platforms offers the potential to create comprehensive cold chain visibility solutions, addressing critical food safety and pharmaceutical compliance challenges. Commercial applications are rapidly expanding beyond basic monitoring, exploring specialized domains such as vaccine distribution, biologics storage, and high-value food transportation. Particularly promising areas include the development of hybrid TTI technologies, advancements in wireless connectivity, and the emergence of AI-powered analytics platforms. The potential for subscription-based monitoring services and specialized compliance solutions represents a significant frontier of market expansion. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) – Market Challenges Standardization requirements across different regions and complex integration with existing supply chain systems continue to create implementation barriers. Infrastructure development remains a critical constraint, particularly in developing comprehensive cold chain monitoring networks and managing data privacy concerns. Economic challenges include high costs of advanced electronic TTI solutions, limited awareness in developing regions, and the intricate balance between functionality and affordability. Manufacturers must also navigate varying regulatory requirements, address reliability concerns, and work to gain widespread adoption across diverse industry verticals. Segment Insights The global Time Temperature Indicator market demonstrates nuanced segmentation across multiple critical dimensions. The Chemical-based TTI Technology segment is expected to hold the largest market share in 2025 and grow at the highest CAGR through 2035, due to cost-effectiveness and reliability. On the basis of label information, Time Temperature Indicators (TTI) are projected to dominate the market, with Critical Time Temperature Indicators (CTTI) anticipated to grow rapidly due to pharmaceutical compliance requirements. On the basis of end user, Food & Beverage will hold the largest market share in 2025, while Pharmaceutical & Healthcare is projected to grow at a significant CAGR from 2025-2035, highlighting the critical importance of temperature control in drug storage and vaccine distribution. Request a customized research analysis tailored to your specific requirements: Geographic Market Insights North America is expected to hold a significant market share in 2025, attributed to substantial regulatory compliance requirements and advanced cold chain infrastructure. However, the Asia-Pacific region is projected to witness the highest growth rate, driven by rapid industrialization, expanding cold chain infrastructure, and growing awareness of food safety regulations. China leads the region with the largest market share in cold chain logistics, while India follows with significant investments in rural cold storage facilities. Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More)- Competitive Landscape The global time temperature indicator market features a diverse and dynamic competitive landscape. Established packaging and monitoring solution providers are competing alongside innovative technology companies, each pursuing unique approaches to TTI development and smart packaging integration. Key players operating in the overall time temperature indicator market include 3M Company, DeltaTrak Inc., Temptime Corporation (Zebra Technologies), Vitsab International AB, American Thermal Instruments, Timestrip UK Ltd., Insignia Technologies Ltd., SpotSee (Formerly ShockWatch), Berlinger & Co. AG, among others. Related Reports: Cold Chain Equipment Market by Size, Share, Forecasts, & Trends Analysis Temperature Sensors Market Size, Share, & Growth Report 2032 Weather Monitoring Systems Market to Hit $4.49B by 2032 About Meticulous Research We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact:Mr. Khushal BombeMeticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@ Our Website: with us on LinkedIn- Source: Logo: View original content:

KYOCERA AVX Earned a Silver 2024 TTI Asia Supplier Excellence Award
KYOCERA AVX Earned a Silver 2024 TTI Asia Supplier Excellence Award

Yahoo

time19-05-2025

  • Business
  • Yahoo

KYOCERA AVX Earned a Silver 2024 TTI Asia Supplier Excellence Award

The award recognizes KYOCERA AVX for its unwavering commitment to outstanding quality, reliability, and service. FOUNTAIN INN, S.C., May 19, 2025 /PRNewswire/ -- KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, earned a Silver 2024 TTI Asia Supplier Excellence Award. Bestowed by TTI, Inc., the world's leading authorized specialty distributor of interconnect, passive, and electromechanical (IP&E) components, the Silver 2024 TTI Asia Supplier Excellence Award celebrates KYOCERA AVX for faithfully fulfilling critical quality performance metrics designed to elevate supplier and distributor performance and achieve maximum customer satisfaction throughout Asia. Launched in 2007, the annual TTI Asia Supplier Excellence Awards recognize suppliers for superlative performance within Asia as it relates to quality acceptance, ship-to-commit delivery dates, effective business systems, ease of doing business, and both the quality and efficacy of field employee and management relationships. The 2024 TTI Asia Supplier Excellence Award honors KYOCERA AVX for its faithful fulfillment of crucial performance metrics including on-time delivery, receiving quality, customer-reported quality, administrative quality, operations and business systems, and sales and management support. Kingsley Wong, President of TTI Asia, presented the award to Stanley Sung, Vice President of Sales – Asia, KYOCERA AVX, on April 16, 2025, during Electronica Shanghai. "The KYOCERA AVX team, and especially the KYOCERA AVX Asia team, is thrilled to have earned another TTI Asia Supplier Excellence Award," said Stanley Sung, Vice President of Sales – Asia, KYOCERA AVX. "We are committed to providing outstanding quality, reliability, and service; so, it's a real honor to have one of our highly valued strategic partners celebrate our success in this regard. Our team is committed to consistently exceeding quality performance standards and providing exemplary customer service, and we look forward to further strengthening our partnership with TTI Asia in 2025." To learn more about KYOCERA AVX and its partnership with TTI Asia, please visit the links embedded here, follow them on LinkedIn, Twitter, and Instagram, like them on Facebook, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644. About TTITTI, Inc., a Berkshire Hathaway company, is an authorized, specialty distributor of electronic components. Founded in 1971, the emphasis on a broad and deep product portfolio, available-to-sell inventory and sophisticated supply chain programs has established TTI as a distributor of choice to manufacturers in the industrial, defense, aerospace, transportation, medical, and communications sectors worldwide. TTI and its wholly owned subsidiaries, the TTI Family of Specialists, Mouser Electronics, Sager Electronics, and the Exponential Technology Group, employ over 9,000 people in more than 136 locations throughout the Americas, Europe, Asia, and Africa. Globally, the TTI Family of Specialists maintain over 3 million square feet of dedicated warehouse space in 30 distribution centers. For more information about TTI, visit About KYOCERA AVXKYOCERA AVX is a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future. As a wholly owned subsidiary of Kyocera Corporation structured to capitalize on shared resources and technical expertise, KYOCERA AVX has an expansive global footprint comprised of several dozen research, development, and manufacturing facilities spanning more than 15 countries and staffed with talented personnel dedicated to innovation, component quality, customer service, and enabling a brighter future through technology. KYOCERA AVX designs, develops, manufactures, and supplies advanced capacitors, antennas, interconnects, circuit protection and timing devices, sensors, controls, filters, fuses, diodes, resistors, couplers, and inductors optimized for employment in the international 5G, IoT, aerospace, automotive, consumer electronics, industrial, medical, and military markets. PR Image Downloads:KAVX119 TTI Asia Supplier Excellence Award PR (Trophy).jpgKAVX119 TTI Asia Supplier Excellence Award PR (Team).jpg Pictured from left to right in the (Team) photo are: Jennifer Chen, Branch Product Manager, TTI Asia CK Ng, Director of Supplier Business Management, TTI Asia Mark Dong, Marketing Senior Manager – MLCCs, Asia, KYOCERA AVX Michael Pan, Vice President of Sales – China, TTI Asia Stanley Sung, Vice President of Sales – Asia, KYOCERA AVX Kingsley Wong, President, TTI Asia Andy Ko, Marketing Director – Asia, KYOCERA AVX Jim Hawersaat, Senior Vice President Global Transportation Business, TTI Inc William Chow, Senior Director of Product Management, TTI Asia Maz Chui, Distribution Manager – Asia, KYOCERA AVX View original content to download multimedia: SOURCE KYOCERA AVX

Councillor urges men to get tested following stage 4 prostate cancer diagnosis
Councillor urges men to get tested following stage 4 prostate cancer diagnosis

Pembrokeshire Herald

time14-05-2025

  • Health
  • Pembrokeshire Herald

Councillor urges men to get tested following stage 4 prostate cancer diagnosis

Inquiry told failures in testing and tracing cost lives and left Wales unprepared THE UK Covid Inquiry has begun its latest public hearings with stark criticism of the UK and devolved governments' handling of testing, tracing and isolation strategies during the coronavirus pandemic. On the opening day of Module 7, which focuses on 'Test, Trace and Isolate' (TTI) systems, serious concerns were raised about the Welsh Government's effectiveness, coordination, and long-term preparedness. Covid pandemic: Council staff in Tenby in 2020 (Image: File) Sophie Cartwright KC, lead counsel to the Inquiry, laid out a damning picture of systemic disarray across the four nations, including Wales. She highlighted that despite early warnings and international advice, the Welsh Government did not fully roll out its Test, Trace, Protect strategy until mid-May 2020, by which time the virus had already swept through communities. The Inquiry heard that on 12 March 2020, all four UK nations, including Wales, stopped community testing and contact tracing—despite the World Health Organization's call to 'test, test, test.' Professor Chris Whitty, the Chief Medical Officer, told a COBR meeting that day that mass testing and tracing would no longer be pursued, even as infections surged. The result was, as Cartwright put it, a 'disastrous blind spot' in surveillance and control. While countries like South Korea and Japan avoided national lockdowns through robust test-and-isolate systems, the UK suffered repeated waves. Professor Anthony Costello estimated that over 180,000 deaths might have been prevented had the UK adopted similar strategies. Emotional testimony: Anna-Louise Marsh-Rees Anna-Louise Marsh-Rees, who gave emotional evidence, represents Covid Bereaved Families for Justice Cymru. She spoke on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Her testimony underscored the human impact of delays in testing, isolation support and communication failures. Lack of preparedness and ignored lessons Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, criticised the Welsh Government for failing to act on pandemic preparedness plans. She highlighted that Exercise Shipshape, a 2003 SARS simulation involving Wales, had already identified the importance of being able to test, trace and isolate effectively. Yet, none of those lessons were implemented. Marsh-Rees said there was a clear failure to build resilient infrastructure and no meaningful contingency planning, despite numerous simulations and warnings. Testing failures and wave two disaster Marsh-Rees gave a stark account of the absence of routine and repeat testing during the second wave of Covid-19 in Wales. She revealed that repeat testing of patients wasn't introduced until January 2021, and even then only every five days—compared to every three in England. Worse, healthcare workers were not regularly tested until February or March 2021, despite lateral flow tests being available from November 2020. She stated bluntly that this oversight contributed to Wales having the highest rate of hospital-acquired (nosocomial) infections in the UK, calling it one of the group's most heartbreaking concerns. A sense the Welsh Government didn't want to know In her closing remarks, Marsh-Rees accused the Welsh Government of appearing as though it did not want to know if people were testing positive, implying that awareness would have triggered obligations to act. She pointed out that 178 people had contracted Covid in Welsh hospitals just last week, five years into the pandemic. 'Testing has been forgotten—or proactively not undertaken,' she said. 'It's like a concerted effort not to find out.' Her testimony called for an internationally informed overhaul of public health strategy and an end to political point scoring in future pandemic response. Missed opportunities in Wales Wales launched its Test, Trace, Protect plan on 13 May 2020. Then Health Minister Vaughan Gething promised increased capacity and localised response. But the Inquiry was told that testing capacity remained limited, with many key functions outsourced to UK-wide services like Lighthouse Labs and delivery partners like Amazon, rather than utilising existing NHS and university laboratories in Wales. A submission from the Royal College of Pathologists noted that many NHS and academic labs in the UK were sidelined, despite offering higher quality and faster results than the private facilities that were favoured instead. The Microbiology Society echoed these concerns, saying the government did not properly engage with universities and local experts in Wales and elsewhere. The Inquiry heard that by mid-2020, Wales had access to six drive-through test centres, eight mobile units and a handful of community testing sites—but by then the damage had already been done. Support for isolating 'too little, too late' The Welsh Government's Self-Isolation Support Scheme, launched in November 2020, was described as well-intentioned but too slow in implementation. Earlier schemes in Northern Ireland and England had started months prior. Evidence submitted highlighted how economic necessity led many to avoid testing to avoid losing income. 'I remember people saying, 'I can't test because if I test and I'm positive, I can't work,'' one person told the Inquiry. Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, will give impact evidence later this week, speaking on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Infrastructure dismantled Lord Bethell, who had responsibility for TTI at UK level, warned that the UK is now less prepared than ever for a future pandemic, with testing labs dismantled, data systems shut down, and public health infrastructure 'weaker than ever.' The Inquiry continues this week with further evidence from bereaved families, scientists, and public health experts from across the UK. Lady Hallett opened the TTI hearings on Monday (Pic: Covid Inquiry)

Tufnell secures pledge to improve GP access across Pembrokeshire
Tufnell secures pledge to improve GP access across Pembrokeshire

Pembrokeshire Herald

time14-05-2025

  • Health
  • Pembrokeshire Herald

Tufnell secures pledge to improve GP access across Pembrokeshire

Inquiry told failures in testing and tracing cost lives and left Wales unprepared THE UK Covid Inquiry has begun its latest public hearings with stark criticism of the UK and devolved governments' handling of testing, tracing and isolation strategies during the coronavirus pandemic. On the opening day of Module 7, which focuses on 'Test, Trace and Isolate' (TTI) systems, serious concerns were raised about the Welsh Government's effectiveness, coordination, and long-term preparedness. Covid pandemic: Council staff in Tenby in 2020 (Image: File) Sophie Cartwright KC, lead counsel to the Inquiry, laid out a damning picture of systemic disarray across the four nations, including Wales. She highlighted that despite early warnings and international advice, the Welsh Government did not fully roll out its Test, Trace, Protect strategy until mid-May 2020, by which time the virus had already swept through communities. The Inquiry heard that on 12 March 2020, all four UK nations, including Wales, stopped community testing and contact tracing—despite the World Health Organization's call to 'test, test, test.' Professor Chris Whitty, the Chief Medical Officer, told a COBR meeting that day that mass testing and tracing would no longer be pursued, even as infections surged. The result was, as Cartwright put it, a 'disastrous blind spot' in surveillance and control. While countries like South Korea and Japan avoided national lockdowns through robust test-and-isolate systems, the UK suffered repeated waves. Professor Anthony Costello estimated that over 180,000 deaths might have been prevented had the UK adopted similar strategies. Emotional testimony: Anna-Louise Marsh-Rees Anna-Louise Marsh-Rees, who gave emotional evidence, represents Covid Bereaved Families for Justice Cymru. She spoke on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Her testimony underscored the human impact of delays in testing, isolation support and communication failures. Lack of preparedness and ignored lessons Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, criticised the Welsh Government for failing to act on pandemic preparedness plans. She highlighted that Exercise Shipshape, a 2003 SARS simulation involving Wales, had already identified the importance of being able to test, trace and isolate effectively. Yet, none of those lessons were implemented. Marsh-Rees said there was a clear failure to build resilient infrastructure and no meaningful contingency planning, despite numerous simulations and warnings. Testing failures and wave two disaster Marsh-Rees gave a stark account of the absence of routine and repeat testing during the second wave of Covid-19 in Wales. She revealed that repeat testing of patients wasn't introduced until January 2021, and even then only every five days—compared to every three in England. Worse, healthcare workers were not regularly tested until February or March 2021, despite lateral flow tests being available from November 2020. She stated bluntly that this oversight contributed to Wales having the highest rate of hospital-acquired (nosocomial) infections in the UK, calling it one of the group's most heartbreaking concerns. A sense the Welsh Government didn't want to know In her closing remarks, Marsh-Rees accused the Welsh Government of appearing as though it did not want to know if people were testing positive, implying that awareness would have triggered obligations to act. She pointed out that 178 people had contracted Covid in Welsh hospitals just last week, five years into the pandemic. 'Testing has been forgotten—or proactively not undertaken,' she said. 'It's like a concerted effort not to find out.' Her testimony called for an internationally informed overhaul of public health strategy and an end to political point scoring in future pandemic response. Missed opportunities in Wales Wales launched its Test, Trace, Protect plan on 13 May 2020. Then Health Minister Vaughan Gething promised increased capacity and localised response. But the Inquiry was told that testing capacity remained limited, with many key functions outsourced to UK-wide services like Lighthouse Labs and delivery partners like Amazon, rather than utilising existing NHS and university laboratories in Wales. A submission from the Royal College of Pathologists noted that many NHS and academic labs in the UK were sidelined, despite offering higher quality and faster results than the private facilities that were favoured instead. The Microbiology Society echoed these concerns, saying the government did not properly engage with universities and local experts in Wales and elsewhere. The Inquiry heard that by mid-2020, Wales had access to six drive-through test centres, eight mobile units and a handful of community testing sites—but by then the damage had already been done. Support for isolating 'too little, too late' The Welsh Government's Self-Isolation Support Scheme, launched in November 2020, was described as well-intentioned but too slow in implementation. Earlier schemes in Northern Ireland and England had started months prior. Evidence submitted highlighted how economic necessity led many to avoid testing to avoid losing income. 'I remember people saying, 'I can't test because if I test and I'm positive, I can't work,'' one person told the Inquiry. Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, will give impact evidence later this week, speaking on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Infrastructure dismantled Lord Bethell, who had responsibility for TTI at UK level, warned that the UK is now less prepared than ever for a future pandemic, with testing labs dismantled, data systems shut down, and public health infrastructure 'weaker than ever.' The Inquiry continues this week with further evidence from bereaved families, scientists, and public health experts from across the UK. Lady Hallett opened the TTI hearings on Monday (Pic: Covid Inquiry)

Covid Inquiry: Welsh Government's pandemic response under fire
Covid Inquiry: Welsh Government's pandemic response under fire

Pembrokeshire Herald

time14-05-2025

  • Health
  • Pembrokeshire Herald

Covid Inquiry: Welsh Government's pandemic response under fire

Inquiry told failures in testing and tracing cost lives and left Wales unprepared THE UK Covid Inquiry has begun its latest public hearings with stark criticism of the UK and devolved governments' handling of testing, tracing and isolation strategies during the coronavirus pandemic. On the opening day of Module 7, which focuses on 'Test, Trace and Isolate' (TTI) systems, serious concerns were raised about the Welsh Government's effectiveness, coordination, and long-term preparedness. Covid pandemic: Council staff in Tenby in 2020 (Image: File) Sophie Cartwright KC, lead counsel to the Inquiry, laid out a damning picture of systemic disarray across the four nations, including Wales. She highlighted that despite early warnings and international advice, the Welsh Government did not fully roll out its Test, Trace, Protect strategy until mid-May 2020, by which time the virus had already swept through communities. The Inquiry heard that on 12 March 2020, all four UK nations, including Wales, stopped community testing and contact tracing—despite the World Health Organization's call to 'test, test, test.' Professor Chris Whitty, the Chief Medical Officer, told a COBR meeting that day that mass testing and tracing would no longer be pursued, even as infections surged. The result was, as Cartwright put it, a 'disastrous blind spot' in surveillance and control. While countries like South Korea and Japan avoided national lockdowns through robust test-and-isolate systems, the UK suffered repeated waves. Professor Anthony Costello estimated that over 180,000 deaths might have been prevented had the UK adopted similar strategies. Emotional testimony: Anna-Louise Marsh-Rees Anna-Louise Marsh-Rees, who gave emotional evidence, represents Covid Bereaved Families for Justice Cymru. She spoke on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Her testimony underscored the human impact of delays in testing, isolation support and communication failures. Lack of preparedness and ignored lessons Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, criticised the Welsh Government for failing to act on pandemic preparedness plans. She highlighted that Exercise Shipshape, a 2003 SARS simulation involving Wales, had already identified the importance of being able to test, trace and isolate effectively. Yet, none of those lessons were implemented. Marsh-Rees said there was a clear failure to build resilient infrastructure and no meaningful contingency planning, despite numerous simulations and warnings. Testing failures and wave two disaster Marsh-Rees gave a stark account of the absence of routine and repeat testing during the second wave of Covid-19 in Wales. She revealed that repeat testing of patients wasn't introduced until January 2021, and even then only every five days—compared to every three in England. Worse, healthcare workers were not regularly tested until February or March 2021, despite lateral flow tests being available from November 2020. She stated bluntly that this oversight contributed to Wales having the highest rate of hospital-acquired (nosocomial) infections in the UK, calling it one of the group's most heartbreaking concerns. A sense the Welsh Government didn't want to know In her closing remarks, Marsh-Rees accused the Welsh Government of appearing as though it did not want to know if people were testing positive, implying that awareness would have triggered obligations to act. She pointed out that 178 people had contracted Covid in Welsh hospitals just last week, five years into the pandemic. 'Testing has been forgotten—or proactively not undertaken,' she said. 'It's like a concerted effort not to find out.' Her testimony called for an internationally informed overhaul of public health strategy and an end to political point scoring in future pandemic response. Missed opportunities in Wales Wales launched its Test, Trace, Protect plan on 13 May 2020. Then Health Minister Vaughan Gething promised increased capacity and localised response. But the Inquiry was told that testing capacity remained limited, with many key functions outsourced to UK-wide services like Lighthouse Labs and delivery partners like Amazon, rather than utilising existing NHS and university laboratories in Wales. A submission from the Royal College of Pathologists noted that many NHS and academic labs in the UK were sidelined, despite offering higher quality and faster results than the private facilities that were favoured instead. The Microbiology Society echoed these concerns, saying the government did not properly engage with universities and local experts in Wales and elsewhere. The Inquiry heard that by mid-2020, Wales had access to six drive-through test centres, eight mobile units and a handful of community testing sites—but by then the damage had already been done. Support for isolating 'too little, too late' The Welsh Government's Self-Isolation Support Scheme, launched in November 2020, was described as well-intentioned but too slow in implementation. Earlier schemes in Northern Ireland and England had started months prior. Evidence submitted highlighted how economic necessity led many to avoid testing to avoid losing income. 'I remember people saying, 'I can't test because if I test and I'm positive, I can't work,'' one person told the Inquiry. Anna-Louise Marsh-Rees, representing Covid Bereaved Families for Justice Cymru, will give impact evidence later this week, speaking on behalf of families in Wales who lost loved ones due to what they describe as 'avoidable government failings.' Infrastructure dismantled Lord Bethell, who had responsibility for TTI at UK level, warned that the UK is now less prepared than ever for a future pandemic, with testing labs dismantled, data systems shut down, and public health infrastructure 'weaker than ever.' The Inquiry continues this week with further evidence from bereaved families, scientists, and public health experts from across the UK. Lady Hallett opened the TTI hearings on Monday (Pic: Covid Inquiry)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store